Parent and Child Cognitive Behavioural Therapy for Anxiety Disorders

Not Applicable

Completed

• Conditions: Anxiety Disorders; Mental Health - Anxiety

• Registration Number: ACTRN12619000334101
• Lead Sponsor: Associate Professor Marie Yap

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-04
• Study Completion: 2020-07-22
• Last Update Posted: 10 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Adult/Parent Participants:
Adult 18+ years of age, with a DSM-V primary diagnosis of an anxiety disorder, who has one child with a DSM-V primary diagnosis of an anxiety disorder.

Child Participants:
Primary school aged children (6-12 years) with a DSM-V primary diagnosis of an anxiety disorder, who has one parent with a DSM-V primary diagnosis of an anxiety disorder.

Exclusion Criteria

Adult/Parent Participants:
-Primary DSM-V diagnosis other than an anxiety disorder.
-Inability to read and communicate in English sufficiently to understand and participate in assessment and treatment with English-speaking therapists.
-Evidence of dementia or other neurocognitive condition that might interfere with informed consent, or understanding and participating in treatment.
-Evidence of serious suicidality, current alcohol or illicit substance dependence, or any other condition of sufficient severity that requires immediate clinical prioritisation.

Child Participants:
-Primary DSM-V diagnosis other than an anxiety disorder.
-Inability to read and communicate in English sufficiently to understand and participate in assessment and treatment with English-speaking therapists.
-Evidence of a neurocognitive/neurodevelopmental condition that might interfere with understanding and participating in treatment.
-Evidence of serious suicidality or any other condition of sufficient severity that requires immediate clinical prioritisation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adult/Parent Participants:<br>Examining the change in indices of anxiety severity from baseline and post-treatment. For adult parent participants, anxiety severity scores will be obtained from the Clinician Severity Rating in the Anxiety Diagnostic Interview Schedule Version 5 (ADIS-5).[Baseline, and within 4 weeks post-treatment.];Child Participants:<br>Examining the change in indices of anxiety severity from baseline and post-treatment. For child participants, anxiety severity scores will be obtained from the Clinician Severity Rating in the Anxiety Diagnostic Interview Schedule Parent/Child Version 4 (ADIS-4 P/C). [Baseline, and within 4 weeks post-treatment.]

Secondary Outcome Measures

Name	Time	Method
Adult/Parent participants: Measure changes in parenting behaviours throughout treatment using pre- and post-treatment scores on the Parental Stress Scale.[Baseline and Week 10 of treatment.];Adult/Parent participants: Measure changes in parenting behaviours throughout treatment using pre- and post-treatment scores on the Parental Overprotection Measure.[Baseline and Week 10 of treatment.];Adult/Parent participants: Measure changes in parenting behaviours throughout treatment using pre- and post-treatment scores on the Parent Worry Measure.[Baseline and Week 10 of treatment.]